NEW YORK (Real Money) -- Nobody likes to leave the comfort zone, and it has been ages since you had to. I am talking about the comfort zone of low-growth, dividend-related choices exemplified by thoughts such as:
- Do I own Bristol-Myers Squibb (BMY) or should I swap to Merck (MRK)?
- Or Colgate-Palmolive (CL) has more upside than Procter & Gamble (PG), but Procter has that nice dividend and could restructure.
- Or, most of all, Dominion (D) vs. Con Ed (ED) -- which is it going to be?
When you have an employment number such as last Thursday's, it causes you to have to dust off the playbook for a more aggressive moment. It's been so long since this has occurred that I took heat advocating it on air from critics who no doubt have only lived through the Great Recession and its aftermath.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV